ATAD1 and malaria: A number of antigens expressed on the surface of the Plasmodium falciparum merozoite, including the merozoite surface protein 1 (MSP1) and 3 (MSP3) have been validated as malaria vaccine candidates [4, 5] due to their ability to induce protective antibodies against malaria.